RIGL icon

Rigel Pharmaceuticals
RIGL

Overview Fund Activity

107 hedge funds and large institutions have $210M invested in Rigel Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 31 increasing their positions, 42 reducing their positions, and 27 closing their positions.

Holders
107
Holders Change
-14
Holders Change %
-11.57%
% of All Funds
2.68%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
14
Increased
31
Reduced
42
Closed
27
Calls
$202K
Puts
$262K
Net Calls
-$60K
Net Calls Change
-$2.05M

Top Buyers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$25.1M
2
BBA
2
Baker Bros. Advisors
New York
$4.81M
3
CAM
3
Cormorant Asset Management
Massachusetts
$6.83M
4
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$4.08M
5
Fidelity Investments
5
Fidelity Investments
Massachusetts
$35.3M

Top Sellers

1
BC
1
Boxer Capital
California
$0
2
SAM
2
Senzar Asset Management
New York
$0
3
Goldman Sachs
3
Goldman Sachs
New York
$1.47M
4
EI
4
EAM Investors
California
$0
5
PAI
5
Palo Alto Investors
California
$9.94M
Name Holding Trade Value Shares
Change 		Shares
Change %
Jane Street
126
Jane Street
New York
– -$40K -1,082 Closed
PHK
127
Point72 Hong Kong
Hong Kong
– -$26K -720 Closed
Simplex Trading
128
Simplex Trading
Illinois
– -$18K -497 Closed
AIM
129
Acrospire Investment Management
Illinois
– -$9K -246 Closed
Bank of Montreal
130
Bank of Montreal
Ontario, Canada
– -$6K -150 Closed
2 3 4 5
6